Paul B. Freeman OD, FAAO, FOVDR
Chief, Low Vision Rehabilitation Services, Allegheny General Hospital, Pittsburgh, Pennsylvania; Clinical Professor, University of the Incarnate Word, Rosenberg School of Optometry, San Antonio, TexasDr. Paul B. Freeman is the Chief of Low Vision Rehabilitation Services at Allegheny General Hospital in Pittsburgh, Pennsylvania, and he provides low vision rehabilitation services at Keystone Blind Association in Hermitage, Pennsylvania, and at Beaver County Association for the Blind in Conway, Pennsylvania. Dr. Freeman is also a Clinical Professor at the University of the Incarnate Word, Rosenberg School of Optometry in San Antonio, Texas.
Dr. Freeman’s clinical interests include visual impairment, traumatic brain injury, visual aspects of driving, and learning-related vision problems. He has been an investigator in a number of vision research projects to determine the efficacy of sophisticated low vision devices, to assess the psychological implications of low vision, and to explore the relationship of vision and the learning process.
A Fellow of the American Academy of Optometry and a Diplomate in Low Vision, Dr. Freeman is also a Fellow of Optometric Vision Development and Rehabilitation Association. He lectures both nationally and internationally and has authored numerous articles and book chapters. Currently, he is Editor-in-Chief of Optometric Clinical Practice.
Recent Contributions to PracticeUpdate:
- Physical Therapy Interventions in Bell’s Palsy
- Update on Myopia and Treatment Strategy of Atropine Use in Myopia Control
- Frequency of Visual Deficits in Children With Developmental Dyslexia
- Longitudinal Associations Between Visual Impairment and Cognitive Functioning
- Five-Year Postoperative Outcomes of Bilateral Aphakia and Pseudophakia in Children Up to 2 Years of Age
- Trends in US Emergency Department Visits for Pediatric Acute Ocular Injury
- The Value of an Eye Exam in Patients With COPD
- Guidelines on Diabetic Eye Care
- Outcomes of Cataract Surgery in Patients With Exudative Age-Related Macular Degeneration and Macular Fluid
- New Recommendations for the Treatment of Systemic Hypertension and Potential Implications for Glaucoma Management